Neural Therapeutics (FRA:M6B) Buildings And Improvements : €0.00 Mil (As of Jan. 2025)

View and export this data going back to 2025. Start your Free Trial

What is Neural Therapeutics Buildings And Improvements?

Neural Therapeutics Buildings And Improvements Historical Data

The historical data trend for Neural Therapeutics's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neural Therapeutics Buildings And Improvements Chart

Neural Therapeutics Annual Data

Trend

Jul20

Jul21

Jul22

Jul23

Jul24

Buildings And Improvements

Neural Therapeutics Quarterly Data
	Jul20	Jul21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Buildings And Improvements	Get a 7-Day Free Trial										-	-	-	-	-

Neural Therapeutics Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Neural Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neural Therapeutics Inc (FRA:M6B) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

NURL:Canada

Address

130 Adelaide Street, Suite 3002, Toronto, ON, CAN, M5H 3P5

Website

https://www.neuraltherapeutics.ca

Neural Therapeutics Inc is a wholly-owned subsidiary of High Fusion focused on ethnobotanical drug discovery and development company. Neural Therapeutics is focused on developing products and conducting research on the psychoactive cacti plants with the primary objective to find where the historical use in traditional medicine proves to be effective and capitalizing on the opportunities that can be applied in modern medical and natural health products markets.

Neural Therapeutics Headlines

No Headlines